| Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 |
|---|---|---|---|---|---|---|---|---|
Net sales | ||||||||
16,820 | 0 | 0 | 0 | - | - | - | - | - |
Cost of goods sold | ||||||||
8,811 | 0 | 0 | - | - | - | - | - | - |
Gross profit | ||||||||
8,009 | 0 | 0 | - | - | - | - | - | - |
Costs and expenses: | ||||||||
Research and development | ||||||||
48,346 | 87,056 | 78,028 | 83,274 | 50,630 | 29,294 | 13,419 | 9,559 | 3,732 |
Selling, general and administrative | ||||||||
181,862 | 58,230 | 21,794 | 11,004 | 11,681 | - | - | - | - |
Purchased in-process research and development | ||||||||
- | - | - | - | - | 1,000 | - | - | - |
General and administrative | ||||||||
- | - | - | - | - | 7,941 | 6,745 | 6,562 | 4,467 |
Loss from operations | ||||||||
-222,199 | -145,286 | -99,822 | -94,278 | -62,311 | -38,235 | -20,164 | -16,121 | -8,200 |
Other Income (Expense) | ||||||||
Interest expense, net | ||||||||
5,270 | 13,390 | 17,284 | - | - | - | 12 | - | - |
Interest and investment expense, net | ||||||||
- | - | - | -2,875 | 38 | - | - | - | - |
Debt conversion expense | ||||||||
1,209 | 40,158 | 0 | 0 | - | - | - | - | - |
State R&D tax credits | ||||||||
0 | 121 | 0 | 83 | - | - | - | - | - |
Tax credits | ||||||||
- | - | - | - | - | 506 | 362 | 494 | - |
Interest and investment income/ (expense), net (includes interest expense of $3,750 on Senior Convertible Debentures for the three months ended March 31, 2015 | ||||||||
- | - | - | - | - | 218 | 90 | 109 | 74 |
Change in fair value of derivative financial instruments-warrants | ||||||||
4,340 | 106 | -394 | 1,362 | 149 | -1,933 | 5,257 | 297 | - |
Total other expense | ||||||||
-2,139 | -53,321 | -17,678 | -1,430 | 187 | -1,209 | 5,697 | 900 | 74 |
Loss from Continuing Operations | ||||||||
- | - | - | - | - | - | -14,467 | -15,221 | -8,125 |
Net loss | ||||||||
-224,338 | -198,607 | -117,500 | -95,708 | -62,124 | -39,444 | -14,467 | -15,221 | -8,125 |
Weighted Average Common Shares Outstanding | ||||||||
Basic and Diluted (in shares) | ||||||||
225,439 | 164,437 | 105,570 | 94,276 | 85,220 | 61,702 | 47,598 | 44,875 | - |
Net Loss per Common Share, Basic and Diluted | ||||||||
Weighted Average Common Shares Outstanding Basic (restated for stock split) (in shares) | ||||||||
- | - | - | - | - | - | - | - | 36,640 |
Weighted Average Common Shares Outstanding Diluted (restated for stock split) (in shares) | ||||||||
- | - | - | - | - | - | - | - | 36,640 |
Net Loss per Common Share, Basic and Diluted (in dollars per share) | ||||||||
-1.00 | -1.21 | -1.11 | -1.02 | -0.73 | -0.64 | -0.30 | -0.34 | -0.22 |